The New York Times Company (NYT) Market Cap & Valuation Ratios
The New York Times Company (NYT) has a market cap of $11.2B, a trailing P/E of 29.0 and a price-to-sales ratio of 3.8, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NYTThe New York Times CompanyFollow NYT — free
—
Price chart with a free account
- Market cap
- 11.2B
- P/E TTM
- 29.0
- Dividend yield
- 1.2%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Peers
publishing · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| NYT | 11 | 29.0 | 3.5 | 18.9 | 5.6% | +11% | 16% | 21% |
| MH | 2.8 | 30.5 | 2.4 | 7.9 | 12.0% | +0.1% | 14% | 7% |
| WLYB | 2.8 | 14.7 | 2.4 | 10.0 | 8.2% | -0.3% | 15% | 11% |
| WLY | 2.7 | 14.5 | 2.4 | 10.0 | 8.3% | -0.3% | 15% | 11% |
| WBTN | 1.3 | — | 0.5 | — | -0.3% | -0.5% | -4% | -7% |
| TDAY | 1.0 | — | 0.8 | 6.3 | 6.1% | -7% | 7% | 11% |
| SCHL | 0.7 | — | 0.5 | 9.4 | -2.0% | -3% | 1.0% | 1% |
| QUAD | 0.5 | 15.0 | 0.4 | 5.2 | 10.4% | -8% | 4% | 14% |
| PMTS | 0.3 | 23.6 | 0.9 | 6.9 | 24.7% | +17% | 9% | 14% |
| Median of these 8 | 15.0 | 0.9 | 7.9 | 8.2% | -0.4% | 8% | 11% |
P/E 29.0 vs. a peer median of 15.0; EV/Sales 3.5 vs. 0.9. NYT's own P/E sits at the 19th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesWBTN and TDAY and SCHL have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
The New York Times Company — questions
- What is The New York Times Company's market cap?
- $11.2B.
- What is The New York Times Company's P/E ratio?
- 29.0 on trailing twelve-month earnings to 2026-06-30.
- What is The New York Times Company's price-to-sales ratio?
- 3.8.
Every figure on this page comes from The New York Times Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.